X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Weak global cues hurt India 
(Fri, 5 Feb Closing) 
 
Persistent selling activity across index heavyweights led the indices to languish deep in the red and close well below the dotted line in today's trade. While the BSE Sensex closed lower by around 451 points (down 3%), the NSE Nifty lost around 127 points (down 3%). Midcap and small cap stocks were also at the receiving end, notching losses of 3% each. Losses were largely seen in metals, banking and oil & gas stocks.

As regards global markets, most Asian indices closed weak today while European indices have also opened in the red. The rupee was trading at Rs 46.66 to the dollar at the time of writing.

Most pharma stocks closed weak today with Ranbaxy, Wockhardt and Glenmark leading the pack of losers. Ranbaxy closed lower by 5% today. This was seemingly on back of the news that the company has failed to address its issues with the US FDA. The US regulator has asked the company to immediately assess the manufacturing practices at its plants that make drugs for the American market. It must be noted that Ranbaxy was already in trouble when two of its manufacturing plants at Poanta Sahib and Dewas were found to be violating the good manufacturing practices standards of the US FDA in 2008. As if that was not enough, Ranbaxy received another setback when the US FDA issued a warning letter for its manufacturing facility Ohm Laboratories in the US in December 2009. Ohm has meanwhile hired the services of PRTM, a global consulting firm, to provide expertise and advice on issues raised by the FDA. US accounted for around 25% of Ranbaxy's sales in 2008 and is an important market for the company. However, sales from this market have substantially fallen of late due to its impending issues with the US FDA which have been going on for some time now. Unless the company quickly finds some way to resolve these issues, performance of the US business will continue to remain under pressure.

As per a leading business daily Siemens and BEML Ltd have entered into an agreement to jointly manufacture and market stainless steel coaches for suburban rail systems. As per the terms of the contract, Siemens will manufacture high-performance bogies and the three-phase IGBT (insulated gate bipolar transistor) propulsion system, which it is already supplying to Railways. BEML, meanwhile, will make stainless steel EMUs (electric multiple units). Further, the two companies will jointly bid for purchase orders from Indian Railways and suburban train operators such as Mumbai Railway Vikas Corporation Ltd. It must be noted that in the December 2009 quarter, the company's mobility (transportation) segment witnessed a growth of 40% YoY in sales with 11% YoY growth in PBIT margins. Not just that, the company will also be able to capitalise on the growing demand for EMU coaches in major cities which are expanding their suburban rail networks. However, the stock closed lower by 3% today.

As per reports, the IMF has urged India to begin fiscal consolidation with the next budget given that India's fiscal deficit has soared due to various stimulus measures introduced to bolster the economy. It must be noted that India's fiscal deficit surged to 6.2% of GDP in FY09 and the government had pegged this deficit at 6.8% of GDP in FY10. Given that India has started displaying signs of recovery and is growing at a stronger rate than the developed world, the IMF is of the opinion that it is the right time to withdraw the stimulus. However, this may not happen anytime soon. This is because the chief statistician Pronab Sen has stated that India may defer taking a call on exiting stimulus measures and the finance minister could take appropriate steps later in the next fiscal year. Indeed, after the global economic meltdown and the serious problems that it posed, dealing with such a high fiscal deficit is the next big issue that the government will have to tackle going forward.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Weak global cues hurt India". Click here!

2 Responses to "Weak global cues hurt India"

S.V.B.VENKATA RAMANA

Feb 6, 2010

AFTER GLOBALISATION GLOBAL SHOCKS WILL DEFINITELY EFFECT THE INDIAN MAARKETS.THIS IS A PROCESS OF GOOD MONEY CHASING THE BAD MONEY.THERE IS NO CERTINITY IN THE EUROPE AND USA .INTEREST RATES AND BUSINESS OUT LOOK IS BLEAK IN THE DEVELOPED COUNTRIES.NATURALLY MARKETS WILL SHOW SYMPATHY AND RECIPROCATION.

Like 

Mansukh Panchamia

Feb 5, 2010

I was shocked by very poor perfomance of Indian stock market lately.Weak global cues hurt Indian stock market. I fail to understand the damage done due to abve mentioned irational reasoning.With Indian GDP @7.5%
and ample employment opptunities associated most stable interest rate downfall in the market is unconceivable.

Like 
  
Equitymaster requests your view! Post a comment on "Weak global cues hurt India". Click here!
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Aug 18, 2017 01:13 PM

MARKET STATS